Advanced search

A phase I study in T cell lymphoma patients treated with anti-CD70 simple antibody (TM) ARGX-110

(2016) HAEMATOLOGICA. 101(suppl. 1). p.396-396
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Michot, JM, M Maerevoet, P Aftimos, Sylvie Rottey, C Rolfo, Fritz Offner, L Van Rompaey, et al. 2016. “A Phase I Study in T Cell Lymphoma Patients Treated with anti-CD70 Simple Antibody (TM) ARGX-110.” In Haematologica, 101:396–396.
APA
Michot, J., Maerevoet, M., Aftimos, P., Rottey, S., Rolfo, C., Offner, F., Van Rompaey, L., et al. (2016). A phase I study in T cell lymphoma patients treated with anti-CD70 simple antibody (TM) ARGX-110. HAEMATOLOGICA (Vol. 101, pp. 396–396). Presented at the 21st Congress of the European Hematology Association.
Vancouver
1.
Michot J, Maerevoet M, Aftimos P, Rottey S, Rolfo C, Offner F, et al. A phase I study in T cell lymphoma patients treated with anti-CD70 simple antibody (TM) ARGX-110. HAEMATOLOGICA. 2016. p. 396–396.
MLA
Michot, JM, M Maerevoet, P Aftimos, et al. “A Phase I Study in T Cell Lymphoma Patients Treated with anti-CD70 Simple Antibody (TM) ARGX-110.” Haematologica. Vol. 101. 2016. 396–396. Print.
@inproceedings{8524080,
  articleno    = {abstract E964},
  author       = {Michot, JM and Maerevoet, M and Aftimos, P and Rottey, Sylvie and Rolfo, C and Offner, Fritz and Van Rompaey, L and Moshir, M and de Haard, H and Silence, K and Bagot, M and Pauwels, P and Zwaenepoel, K and Awada, A and Bron, D and Ribrag, V},
  booktitle    = {HAEMATOLOGICA},
  issn         = {0390-6078},
  language     = {eng},
  location     = {Copenhagen, Denmark},
  number       = {suppl. 1},
  pages        = {abstract E964:396--abstract E964:396},
  title        = {A phase I study in T cell lymphoma patients treated with anti-CD70 simple antibody (TM) ARGX-110},
  volume       = {101},
  year         = {2016},
}

Web of Science
Times cited: